News

IICT’s role in developing Covaxin of Bharat Biotech

Our Bureau. Hyderabad | Updated on February 26, 2021

Indian Institute of Chemical Technology (IICT) – CSIR has played a key role in developing Bharat Biotech’s Covid-19 vaccine, Covaxin.

Hyderabad-based IICT helped in the synthesis of Agonist molecules for use in Covaxin. It was approached by Bharat Biotech to develop the synthetic route for the agonist molecule with indigenous chemicals at an affordable price and with highest purity. This agonist molecule has aided in scaling up the production of the adjuvant, IICT said.

“The process technology developed by CSIR-IICT for the agonist molecule is playing an important role in the production of adjuvant for Covaxin,” said Shekhar Mande, DG, CSIR and Secretary, DSIR.

Published on February 26, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like